Hubei Guangji Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 323.308 million compared to CNY 340.870 million a year ago. Operating income was CNY 66.026 million compared to CNY 35.040 million a year ago. Net income was CNY 59.719 million compared to CNY 18.946 million a year ago. Basic earnings per share from continuing operations was CNY 0.1736 compared to CNY 0.0583 a year ago.